Re-profiling of selected FDA approved drug(s) to induce mitochondrial biogenesis in ischemic stroke (Record no. 34738)

MARC details
000 -LEADER
fixed length control field 00867nam a22001937a 4500
040 ## - CATALOGING SOURCE
Transcribing agency Riphah International University
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.1
Author Mark HAL
100 ## - MAIN ENTRY--PERSONAL NAME
Authorship Halima usman (5999)
245 ## - TITLE STATEMENT
Title Re-profiling of selected FDA approved drug(s) to induce mitochondrial biogenesis in ischemic stroke
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication Islamabad
Name of publisher (unpublished)
Date of publication 2020
300 ## - PHYSICAL DESCRIPTION
Extent viii, 56 p.
Illustrations : ill., Col.
Dimensions ; 30 cm.
Accompanying material +CD
500 ## - GENERAL NOTE
General note Submitted in fulfillment of the requirement for the degree of Master of Philosophy in Pharmacology to the Faculty of Pharmaceutical Sciences.
500 ## - GENERAL NOTE
General note Includes bibliographical references.
500 ## - GENERAL NOTE
General note Thesis supervisor: Dr. Fawad Ali Shah
502 ## - DISSERTATION NOTE
Dissertation note Thesis (M.Phil)--Riphah International University, 2020
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Subject Pharmacology
Keywords Occlusion surgery
-- Molecular dynamics
-- Cresyl violet
-- Hematoxylin
-- RIPS
942 ## - ADDED ENTRY ELEMENTS (KOHA)
item type Thesis
Holdings
Not for loan Home library Current library Source of acquisition Full call number Barcode Copy number Koha item type
NOT for LOAN City Campus City Campus Riphah International University 615.1 HAL 52895 1 Thesis
Copyright © 2026 Riphah International University | System Administrator